Serum trans-fatty acid concentration is elevated in young patients with coronary artery disease in Japan

Circulation Journal

Volumn 79, Issue 9, 2015, Pages 2017-2025

  Mori, Kenta ^a   Ishida, Tatsuro ^a   Yasuda, Tomoyuki ^a   Hasokawa, Minoru ^a   Monguchi, Tomoko ^a   Sasaki, Maki ^a   Kondo, Kensuke ^a   Nakajima, Hideto ^a   Shinohara, Masakazu ^a   Shinke, Toshiro ^a   Irino, Yasuhiro ^a   Toh, Ryuji ^a   Nishimura, Kunihiro ^b   Hirata, Kenichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Coronary artery disease; Elaidic acid; Hyperlipidemia; Metabolic syndrome; Trans fatty acid

Indexed keywords

APOLIPOPROTEIN B48; ELAIDIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LINOLELAIDIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANS FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FAT INTAKE; OLEIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLIC SYNDROME X; SMOKING; VERY ELDERLY; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; AGE; BLOOD; CHEMICALLY INDUCED; FAT INTAKE; INCIDENCE; MIDDLE AGED; PREVALENCE;

AGE FACTORS; AGED; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; DIETARY FATS; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OLEIC ACID; PREVALENCE; TRANS FATTY ACIDS;

EID: 84940040838     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0750     Document Type: Article

References (36)

1. Gillman MW, Cupples LA, Gagnon D, Millen BE, Ellison RC, Castelli WP. Margarine intake and subsequent coronary heart disease in men. Epidemiology 1997; 8: 144-149.
2. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341: 581-585.
3. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC. Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994; 89: 94-101.
4. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354: 1601-1613.
5. Katan MB, Zock PL, Mensink RP. Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr 1995; 15: 473-493.
6. Hunter JE. Dietary trans fatty acids: Review of recent human studies and food industry responses. Lipids 2006; 41: 967-992.
7. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
8. Gebauer SK, Psota TL, Kris-Etherton PM. The diversity of health effects of individual trans fatty acid isomers. Lipids 2007; 42: 787-799.
9. Mozaffarian D. Trans fatty acids: Effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006; 7: 29-32.
10. WHO. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003; 916: i-viii, 1-149.
11. Cabinet of Japan Food Safety Committee. Evaluative report on trans fatty acid content in foods: Total confirmation assessment in 2006. Tokyo: Cabinet of Japan Food Safety Committee, 2007 (in Japanese).
12. Yamada M, Sasaki S, Murakami K, Takahashi Y, Uenishi K; Japan Dietetic Students' Study for Nutrition and Biomarkers Group. Association of trans fatty acid intake with metabolic risk factors among free-living young Japanese women. Asia Pac J Clin Nutr 2009; 18: 359-371.
13. Yamada M, Sasaki S, Murakami K, Takahashi Y, Okubo H, Hirota N, et al. Estimation of trans fatty acid intake in Japanese adults using 16-day diet records based on a food composition database developed for the Japanese population. J Epidemiol 2010; 20: 119-127.
14. JCS Joint Working Group. Guidelines for secondary prevention of myocardial infarction (JCS 2011): Digest version. Circ J 2013; 77: 231-248.
15. Kuhnt K, Baehr M, Rohrer C, Jahreis G. Trans fatty acid isomers and the trans-9/trans-11 index in fat containing foods. Eur J Lipid Sci Technol 2011; 113: 1281-1292.
16. Nazari B, Asgary S, Azadbakht L. Fatty acid analysis of Iranian junk food, dairy, and bakery products: Special attention to trans-fats. J Res Med Sci 2012; 17: 952-957.
17. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008; 117: 743-753.
18. Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Prev Med 1995; 24: 308-315.
19. Maruyama K, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, et al. Dietary patterns and risk of cardiovascular deaths among middleaged Japanese: JACC Study. Nutr Metab Cardiovasc Dis 2013; 23: 519-527.
20. Research Program for Risk Assessment Study on Food Safety. Executive summary of effects of dietary trans fatty acids on health in Japanese, 2010. Tokyo: Food Safety Commission of Japan, 2010 (in Japanese).
21. Nakamura M, Ojima S. Dietary pattern and prevention of cardiovascular disease. Jpn J Cardiovasc Dis Prev 2014; 49: 12-18 (in Japanese).
22. Sbrana F, Cocci F, Papa A, Landi P, Sampietro T, Rossi G, et al. Routine laboratory tests to risk-stratify patients with chronic coronary artery disease. J Cardiol 2013; 61: 132-137.
23. Tajika K, Okamatsu K, Takano M, Inami S, Yamamoto M, Murakami D, et al. Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque. Circ J 2012; 76: 2211-2217.
24. Uematsu M, Nakamura T, Sugamata W, Kitta Y, Fujioka D, Saito Y, et al. Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy. Circ J 2014; 78: 151-158.
25. Research Program for Risk Assessment Study on Food Safety. Risk assessment report trans fatty acids in foods, 2012. Tokyo: Food Safety Commission of Japan, 2012 (in Japanese).
26. Smith D, Watts GF, Dane-Stewart C, Mamo JC. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state. Eur J Clin Invest 1999; 29: 204-209.
27. Adiels M, Matikainen N, Westerbacka J, Soderlund S, Larsson T, Olofsson SO, et al. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity. Atherosclerosis 2012; 222: 222-228.
28. Mori K, Ishida T, Yasuda T, Monguchi T, Sasaki M, Kondo K, et al. Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease. Clin Chim Acta 2013; 421: 51-56.
29. Harris WS, Reid KJ, Sands SA, Spertus JA. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007; 99: 154-158.
30. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: The cardiovascular health study. Circulation 2006; 114: 209-215.
31. Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A. Lipotoxicity: Effects of dietary saturated and trans fatty acids. Mediators Inflamm 2013; 2013: 137579.
32. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135: 562-566.
33. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001; 21: 1233-1237.
34. Kondo K, Ishida T, Yasuda T, Nakajima H, Mori K, Tanaka N, et al. Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors. Mol Nutr Food Res 2015; 59: 729-740.
35. Katz AM. Trans-fatty acids and sudden cardiac death. Circulation 2002; 105: 669-671.
36. Soares-Miranda L, Stein PK, Imamura F, Sattelmair J, Lemaitre RN, Siscovick DS, et al. Trans-fatty acid consumption and heart rate variability in 2 separate cohorts of older and younger adults. Circ Arrhythm Electrophysiol 2012; 5: 728-738.